The field of cardio-oncology is growing on both a national and international scale. In this interview, Alex Lyon, MA, BM BCh, PhD, FRCP, from Imperial College, London, UK, talks about the formation of the British Cardio-Oncology Society in the UK, and the collaboration between the European Society of Cardiology and the European Society for Medical Oncology for Europe. These organizations aim to promote research and best clinical practice, and to improve the understanding of cardiovascular adverse event following cancer treatment. Dr Lyons highlights the annual Global Cardio-Oncology Summit, as well as other training and development opportunities in this field. This interview was recorded at the British Society for Hematology (BSH) 2018 Annual Scientific Meeting, Liverpool, UK.
Alex Lyon, Interview, BSH 2018, General, Treatment, cardiotoxicity, cardiac dysfunction, chemotherapy, disease risk, clinical trials, research, personalized medicine, cardio-oncology, car…
